BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 32714083)

  • 1. Advances and challenges in the prevention and treatment of COVID-19.
    Han YJ; Ren ZG; Li XX; Yan JL; Ma CY; Wu DD; Ji XY
    Int J Med Sci; 2020; 17(12):1803-1810. PubMed ID: 32714083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Wang D; Li Z; Liu Y
    J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Urgent Need for "Common Cold Units" to Study COVID-19.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1152-1153. PubMed ID: 32274988
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
    Yan CX; Li J; Shen X; Luo L; Li Y; Li MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):139-145. PubMed ID: 32220178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
    Jensen JD; Lynch M
    Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
    Zimmermann P; Curtis N
    Pediatr Infect Dis J; 2020 May; 39(5):355-368. PubMed ID: 32310621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: The Need for Immunoprevention at Industrial Scale.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
    [No Abstract]   [Full Text] [Related]  

  • 12. The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
    Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S
    Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
    Li H; Liu Z; Ge J
    J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination prevention for COVID-19.
    Cohen MS; Corey L
    Science; 2020 May; 368(6491):551. PubMed ID: 32381692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.